Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study

To uncover numerous post-COVID symptoms in individuals after SARS-CoV-2 infection and to raise concerns about the consequences for health care planning. Patients declared negative with RTPCR and discharged from the hospital were followed up for three months. The majority of patients who suffered from weakness since discharge are 63 (25.40%), body aches 40 (16.12%), loss of taste 26 (10.48%), and loss of smell 18 (7.25%). The total of reinfected patients in the 4 week was 9 (3.62%), in the 6 week 10 (4.03%), in the 8 week 7 (2.82%), and in the 12 week 11 (4.43%). A total of 54.7% of individuals still have the persistence of symptoms at the end of the 12 week. A significant number of participants developed long-term health issues as a result of post-COVID-19 syndrome. Our findings highlight the importance of initial preventive measures and patient-centered benefit programs in reducing post-COVID-19 complications.